Additionally, Liu et al. demonstrated that genetic variants in PPAR pathway genes, particularly MED1, PRKCA, and PRKCB, may contribute to susceptibility to pancreatic cancer [181]. This evidence concerns the gene PRKCA and familial pancreatic carcinoma.